A randomized, double-blind, placebo-controlled trial of denosumab in men with nonmetastatic prostate cancer receiving androgen deprivation therapy

Description

Contributors: Saad F, Smith M, Egerdie B, Feldman R, Tammela T, Heracek J, Szwedowski M, Ke C, Kupic A, Leder B, Goessl C / Can Urol Assoc J. 2009 June; 3(3 Suppl 1): S5–S20.

Period	28 Jun 2009
Event title	CUA Annual Meeting
Event type	Other
Degree of Recognition	International